Cite

HARVARD Citation

    Badaat, I. et al. (2020). Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndrome. Journal of clinical pathology. 73 (4), pp. 209-212. [Online]. 
  
Back to record